Ted Jenkins | Vice President, Investor Relations & Strategic Finance |
Ankit Mahadevia | Chief Executive Officer |
Kamal Hamed | Chief Medical Officer |
Sat Shukla | Chief Financial Officer |
Gavin Clark-Gartner | Evercore ISI |
Louise Chen | Cantor |
Ritu Baral | Cowen |
Good afternoon and welcome to the Spero Therapeutics' Third Quarter 2022 Financial Results Conference Call. At this time, all participants are in listen-only mode.
Following the company's formal remarks, we will open up the call for questions. Please be advised that this call is being recorded and a replay will be available.
You can find information on the replay and further information related to today's announcement on the Spero Therapeutics website, www.sperotherapeutics.com.